Cargando…

Upregulation of MTHFD2 is associated with PD-L1 activation in bladder cancer via the PI3K/AKT pathway

Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) has been implicated in the etiology of various human malignant tumors; however, its exact role in bladder cancer (BC) remains to be explored. Through reverse transcription-quantitative PCR, western blotting and immunohistochemistry detection of BC t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Xinxi, Liu, Xiaoqiang, Hu, Bing, Liu, Jianyun, Fu, Bin, Zhang, Wensheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869724/ https://www.ncbi.nlm.nih.gov/pubmed/36601741 http://dx.doi.org/10.3892/ijmm.2022.5217

Ejemplares similares

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023)

Immune‐independent acquired resistance to PD‐L1 antibody initiated by PD‐L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib
por: Gao, Yuan, et al.
Publicado: (2023)

Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer
por: Eich, Marie-Lisa, et al.
Publicado: (2019)

Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer
por: Liu, Xi, et al.
Publicado: (2021)

The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation
por: Shang, Man, et al.
Publicado: (2021)

Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway
por: Xu, Tao, et al.
Publicado: (2021)

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease
por: Liu, Hanjun, et al.
Publicado: (2023)

Insulin upregulates betatrophin expression via PI3K/Akt pathway
por: Lu, Puhan, et al.
Publicado: (2017)

Fenofibrate Ameliorates Retinal Pigment Epithelium Injury Induced by Excessive Fat Through Upregulation of PI3K/AKT Signaling
por: Wang, Xue, et al.
Publicado: (2023)

miR-431 regulates granulosa cell function through the IRS2/PI3K/AKT signaling pathway
por: YANG, Lei, et al.
Publicado: (2020)

Arbutin suppresses osteosarcoma progression via miR‐338‐3p/MTHFD1L and inactivation of the AKT/mTOR pathway
por: Wang, Cheng‐Qun, et al.
Publicado: (2020)

MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway
por: Huang, Jun, et al.
Publicado: (2021)

Upregulation of the PI3K/Akt Pathway in the Tumorigenesis of Canine Thyroid Carcinoma
por: Campos, M., et al.
Publicado: (2014)

PD-L1 Induces Epithelial–Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway
por: Fei, Zhenghua, et al.
Publicado: (2019)

MTHFD2- a new twist?
por: Tedeschi, Philip M., et al.
Publicado: (2016)

NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
por: Huang, Tung-Yung, et al.
Publicado: (2020)

Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1(−)PD-L1(+) Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
por: Liu, Min, et al.
Publicado: (2021)

Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
por: Dong, Chao, et al.
Publicado: (2021)

Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016)

MTHFD1 controls DNA methylation in Arabidopsis
por: Groth, Martin, et al.
Publicado: (2016)

Identification of a set of KSRP target transcripts upregulated by PI3K-AKT signaling
por: Ruggiero, Tina, et al.
Publicado: (2007)

Mitochondrial stress and activation of PI3K and Akt survival pathway in bladder ischemia
por: Yang, Jing-Hua, et al.
Publicado: (2017)

Upregulation of miR-214 Induced Radioresistance of Osteosarcoma by Targeting PHLDA2 via PI3K/Akt Signaling
por: Li, Yi, et al.
Publicado: (2019)

Tumor‐associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen
por: Qiu, Shi, et al.
Publicado: (2019)

MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma
por: Li, Hao, et al.
Publicado: (2019)

CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways
por: Tang, Xiyang, et al.
Publicado: (2022)

PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression
por: Zhu, Manhui, et al.
Publicado: (2016)

MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer()()
por: Agarwal, Sumit, et al.
Publicado: (2019)

RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
por: Liu, Bowen, et al.
Publicado: (2018)

CBMS-5 One-carbon metabolism protect glioma cells under glutamine starvation through upregulation of MTHFD2
por: Tanaka, Kazuhiro, et al.
Publicado: (2021)

AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin
por: Chen, Changhao, et al.
Publicado: (2017)

MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
por: Wang, Fang, et al.
Publicado: (2022)

Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
por: You, Daeun, et al.
Publicado: (2017)

Upregulation of GLT-1 via PI3K/Akt Pathway Contributes to Neuroprotection Induced by Dexmedetomidine
por: Peng, Mengyuan, et al.
Publicado: (2019)

TMEA, a Polyphenol in Sanguisorba officinalis, Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling
por: Li, Hong, et al.
Publicado: (2021)

KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer
por: Ma, Yan, et al.
Publicado: (2023)

PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer
por: Liu, Langbiao, et al.
Publicado: (2023)

PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
por: Liu, Shengwei, et al.
Publicado: (2017)

Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
por: Li, Xiuming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_67tncq7otv7ckmtavguju47ige